Catalent
CTLT
#1475
Rank
โ‚ฌ10.63 B
Marketcap
58,58ย โ‚ฌ
Share price
0.00%
Change (1 day)
13.38%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -1,18ย โ‚ฌ

According to Catalent's latest financial reports the company's current EPS (TTM) is -1,19ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 2,09ย โ‚ฌ a decrease over its 2021 EPS that were of 3,02ย โ‚ฌ.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,18ย โ‚ฌ-156.22%
20222,09ย โ‚ฌ-30.58%
20213,02ย โ‚ฌ79.67%
20201,68ย โ‚ฌ114.12%
20190,78ย โ‚ฌ-15%
20180,92ย โ‚ฌ75.44%
20170,53ย โ‚ฌ-22.97%
20160,68ย โ‚ฌ-59.56%
20151,69ย โ‚ฌ282.05%
20140,44ย โ‚ฌ-378.2%
2013-0,16ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,73ย โ‚ฌ-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,69ย โ‚ฌ-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,30ย โ‚ฌ 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
5,90ย โ‚ฌ-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA